{"title":"[ASBMR除骨质疏松症外有关骨和矿物质代谢的临床研究主题]","authors":"Yuichi Takashi","doi":"CliCa1901116120","DOIUrl":null,"url":null,"abstract":"<p><p>This is a brief report summarizing topics in ASBMR 2018 held at Montreal, Canada in September 28th to October 1st, 2018. In this report, I would like to introduce several topics from clinical research concerning bone and mineral metabolism other than osteoporosis. One of the topics in this area is the progress of research and development of drugs for rare skeletal diseases, which have been considered to be difficult to treat. Especially, there were many abstracts concerning burosumab, which is a new therapeutic medicine for FGF23-related hypophosphatemic rickets/osteomalacia. In addition, I will focus on the papers concerning muscle, osteocalcin, vitamin D and microbiota.</p>","PeriodicalId":10389,"journal":{"name":"Clinical calcium","volume":"29 1","pages":"116-120"},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[ASBMR Topics from clinical research concerning bone and mineral metabolism other than osteoporosis.]\",\"authors\":\"Yuichi Takashi\",\"doi\":\"CliCa1901116120\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This is a brief report summarizing topics in ASBMR 2018 held at Montreal, Canada in September 28th to October 1st, 2018. In this report, I would like to introduce several topics from clinical research concerning bone and mineral metabolism other than osteoporosis. One of the topics in this area is the progress of research and development of drugs for rare skeletal diseases, which have been considered to be difficult to treat. Especially, there were many abstracts concerning burosumab, which is a new therapeutic medicine for FGF23-related hypophosphatemic rickets/osteomalacia. In addition, I will focus on the papers concerning muscle, osteocalcin, vitamin D and microbiota.</p>\",\"PeriodicalId\":10389,\"journal\":{\"name\":\"Clinical calcium\",\"volume\":\"29 1\",\"pages\":\"116-120\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical calcium\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/CliCa1901116120\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical calcium","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/CliCa1901116120","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[ASBMR Topics from clinical research concerning bone and mineral metabolism other than osteoporosis.]
This is a brief report summarizing topics in ASBMR 2018 held at Montreal, Canada in September 28th to October 1st, 2018. In this report, I would like to introduce several topics from clinical research concerning bone and mineral metabolism other than osteoporosis. One of the topics in this area is the progress of research and development of drugs for rare skeletal diseases, which have been considered to be difficult to treat. Especially, there were many abstracts concerning burosumab, which is a new therapeutic medicine for FGF23-related hypophosphatemic rickets/osteomalacia. In addition, I will focus on the papers concerning muscle, osteocalcin, vitamin D and microbiota.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
